ArticleEuropean journal of medical research2026
The value of the pronucleus size of human single pronucleus zygotes as a predictor of fertility outcomes in conventional in vitro fertilization: a retrospective cohort study.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEmbryos derived from in vitro fertilization (IVF) single pronucleus (1PN) zygotes can achieve live births. The pronucleus size of 1PN zygotes is related to their embryonic development potential. However, these studies cannot draw clear conclusions because of the limited sample size. Currently, methods for accurately predicting the development potential of 1PN blastocysts on the basis of the pronucleus diameter are lacking. In this study, we aimed to assess the effects of the pronucleus size of human 1PN zygotes derived from conventional IVF on embryological and pregnancy outcomes.
methodsThis retrospective cohort study included 629 IVF-1PN cycles from 514 individuals between May 2023 and April 2024 to observe embryonic development. Pregnancy outcomes were assessed in 36 patients who received their first transfer of single vitrified-warmed blastocysts derived from IVF-1PN zygotes. Human IVF-1PN zygotes were classified into six groups by PN diameter (≤ 20, 25, 30, 35, 40, and ≥ 45 μm), with the cutoff value determined by examining the receiver operating characteristic curve.
resultsCompared with 1PN zygotes with smaller PN diameters, 1PN zygotes with larger PN diameters had significantly greater cleavage rates, blastocyst formation rates, and blastocyst qualities (P < 0.05). The diameter of 1PN zygotes is a valuable indicator for predicting blastocyst formation (AUC = 0.605, cutoff = 32.5 μm). Moreover, the transfer of IVF-1PN blastocysts with different PN diameters resulted in similar pregnancy outcomes (biochemical pregnancy, ongoing pregnancy, and live birth rates).
conclusionsOur results suggest that 1PN zygotes derived from conventional IVF with larger PN diameters have better embryonic development and could be used as predictors of blastocyst formation (> 32.5 μm). However, once the zygotes reach the blastocyst stage, the PN diameter is not associated with pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.